AMERICAN INTERNATIONAL GROUP, INC. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$105,000
-49.0%
12,015
-6.6%
0.00%0.0%
Q4 2021$206,000
-15.6%
12,860
-2.9%
0.00%0.0%
Q3 2021$244,000
+29.1%
13,245
-2.3%
0.00%0.0%
Q2 2021$189,000
+8.0%
13,559
+13.8%
0.00%0.0%
Q1 2021$175,000
-23.9%
11,916
+0.3%
0.00%0.0%
Q4 2020$230,000
+132.3%
11,885
+34.4%
0.00%
Q3 2020$99,000
-16.8%
8,840
+0.4%
0.00%
-100.0%
Q2 2020$119,000
+91.9%
8,802
+15.4%
0.00%
Q1 2020$62,000
-7.5%
7,626
+8.9%
0.00%
Q4 2019$67,000
-8.2%
7,003
+1.7%
0.00%
Q3 2019$73,000
-2.7%
6,888
+5.7%
0.00%
Q2 2019$75,000
+15.4%
6,514
+28.1%
0.00%
Q1 2019$65,000
+91.2%
5,084
-8.4%
0.00%
Q4 2018$34,000
-42.4%
5,548
-0.8%
0.00%
Q3 2018$59,000
-7.8%
5,591
+28.7%
0.00%
Q2 2018$64,000
+16.4%
4,345
+12.7%
0.00%
Q1 2018$55,000
+14.6%
3,857
-5.1%
0.00%
Q4 2017$48,0004,0630.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders